These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14684948)

  • 1. Autologous punch grafting for repigmentation in piebaldism.
    Garg T; Khaitan BK; Manchanda Y
    J Dermatol; 2003 Nov; 30(11):849-50. PubMed ID: 14684948
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimising size and depth of punch grafts in autologous transplantation of vitiligo and piebaldism: a randomised controlled trial.
    Komen L; Vrijman C; Prinsen CA; van der Veen JP; Luiten RM; Wolkerstorfer A
    J Dermatolog Treat; 2017 Feb; 28(1):86-91. PubMed ID: 27309418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus.
    van Geel N; Wallaeys E; Goh BK; De Mil M; Lambert J
    Br J Dermatol; 2010 Dec; 163(6):1186-93. PubMed ID: 20804490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repigmentation of leucodermic defects in piebaldism by dermabrasion and thin split-thickness skin grafting in combination with minigrafting.
    Njoo MD; Nieuweboer-Krobotova L; Westerhof W
    Br J Dermatol; 1998 Nov; 139(5):829-33. PubMed ID: 9892949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis.
    Guerra L; Primavera G; Raskovic D; Pellegrini G; Golisano O; Bondanza S; Kuhn S; Piazza P; Luci A; Atzori F; De Luca M
    Br J Dermatol; 2004 Apr; 150(4):715-21. PubMed ID: 15099368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous cell suspension grafting in segmental vitiligo and piebaldism: a randomized controlled trial comparing full surface and fractional CO
    Lommerts JE; Meesters AA; Komen L; Bekkenk MW; de Rie MA; Luiten RM; Wolkerstorfer A
    Br J Dermatol; 2017 Nov; 177(5):1293-1298. PubMed ID: 28403523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Non-cultured Autologous Epidermal Cell Grafting Resuspended in Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism Lesions: A Randomized Clinical Trial.
    Bertolotti A; Leone G; Taïeb A; Soriano E; Pascal M; Maillard H; van Geel N
    Acta Derm Venereol; 2021 Jul; 101(7):adv00506. PubMed ID: 34230975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.
    Narayan VS; van den Bol LLC; van Geel N; Bekkenk MW; Luiten RM; Wolkerstorfer A
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):1077-1086. PubMed ID: 33428279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of extensive hypomelanosis with autologous cultured epithelium.
    Kumagai N; Uchikoshi T
    Ann Plast Surg; 1997 Jul; 39(1):68-73. PubMed ID: 9229096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal sheet grafts for repigmentation of vitiligo and piebaldism, with a review of surgical techniques.
    Olsson MJ; Juhlin L
    Acta Derm Venereol; 1997 Nov; 77(6):463-6. PubMed ID: 9394984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity.
    Fongers A; Wolkerstorfer A; Nieuweboer-Krobotova L; Krawczyk P; Tóth GG; van der Veen JP
    Br J Dermatol; 2009 Nov; 161(5):1105-11. PubMed ID: 19673878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Epidermal Grafting for Treatment of Depigmented Skin in Piebaldism.
    Maderal AD; Kirsner RS
    Dermatol Surg; 2017 Jan; 43(1):159-160. PubMed ID: 27399941
    [No Abstract]   [Full Text] [Related]  

  • 13. Pigmentary correction of piebaldism by autografts. II. Pathomechanism and pigment spread in piebaldism.
    Selmanowitz VJ
    Cutis; 1979 Jul; 24(1):66-71, 73. PubMed ID: 383410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative outcomes of autologous cultured melanocytes transplantation and non-cultured epidermal cell suspension transplantation in piebaldism patients: A retrospective study.
    Jin R; Hong W; Ye Z; Fu L; Hu W; Xu A
    Skin Res Technol; 2024 Jan; 30(1):e13580. PubMed ID: 38225879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocyte lineage cells in piebald skin.
    Hattori M; Shimizu A; Ishida-Yamamoto A; Wakamatsu K; Ishikawa O
    J Dermatol; 2019 Sep; 46(9):816-818. PubMed ID: 31254302
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous repigmentation in an infant with piebaldism.
    Frances L; Betlloch I; Leiva-Salinas M; Silvestre JF
    Int J Dermatol; 2015 Jun; 54(6):e244-6. PubMed ID: 25773601
    [No Abstract]   [Full Text] [Related]  

  • 17. Repigmentation after autologous miniature punch grafting in segmental vitiligo in North Indian patients.
    Sarkar R; Mehta SD; Kanwar AJ
    J Dermatol; 2001 Oct; 28(10):540-6. PubMed ID: 11732721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension.
    Olsson MJ; Juhlin L
    Br J Dermatol; 2002 Nov; 147(5):893-904. PubMed ID: 12410698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous cell suspension transplantation using a cell extraction device in segmental vitiligo and piebaldism patients: A randomized controlled pilot study.
    Komen L; Vrijman C; Tjin EP; Krebbers G; de Rie MA; Luiten RM; van der Veen JP; Wolkerstorfer A
    J Am Acad Dermatol; 2015 Jul; 73(1):170-2. PubMed ID: 26089056
    [No Abstract]   [Full Text] [Related]  

  • 20. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K; Malakar S; Sarma N; Banerjee U
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.